Thursday, July 17, 2025 7/17/2025

Structure-based discovery of dopamine D1 receptor selective small molecule ligands

Award Number: R44MH112215
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/01/2017
PERIOD OF PERFORMANCE END DATE: 06/30/2023

Group Awards By:

View Award Description

Structure-based discovery of dopamine D1 receptor selective small molecule ligands - Dopamine receptors are a family of G protein-coupled receptors (GPCRs), and can be further divided into D1-like (D1 and D5) and D2-like (D2, D3 and D4) subfamilies. In this proposal, we focus on D1 receptor, which is widely expressed in brain at high levels. Modulation of D1 activity is implicated in the treatment of many psychiatric and neurological disorders, such as schizophrenia, attention deficit hyperactivity disorder, depression, Parkinson's disease and drug addiction. One important strategy for the treatment of these diseases is to bring D1 activity back to a normal level with either agonists or antagonists, or allosteric modulators. Many D1 agonists and antagonists have been developed after decades of ligand-based efforts. However, their clinical applications have been greatly limited by their poor pharmacokinetics, lack of subtype selectivity, and common adverse effects, while the optimization based on these compounds are proven to be challenging due to their limited chemical diversity. Therefore there is a strong need for novel selective D1 receptor antagonists, agonists or allosteric modulators. The goal of this proposal is to solve the crystal structures of D1 in various activity states and identify chemically novel D1 selective agonists, antagonists and allosteric modulators from virtual screening based on these structures. The crystallization part of this proposal will build on the success of solving the structure D1-Gs protein complex internally by ConfometRx. We will aim to improve the resolution of the existing structure and solve more structures of D1 receptor bound to other agonists (dopamine or dopamine-like), antagonists or the compounds identified from virtual screening. Virtual screening efforts of this proposal will aim at identifying chemically novel compounds binding at the orthosteric site and allosteric site(s) of D1 based on the structures. We will also extend our efforts to its close homolog D5 receptor based on homology modeling, as currently there are no truly selective compounds to distinguish the function of these two subtypes. Novel lead compounds will be experimentally validated and subjected to structure-based optimization. This research will ultimately be commercialized by advancing the most promising compound through clinical trials to create a D1-specific drug with minimal side effects, likely in partnership with a large pharmaceutical company. This proposal is in response to the NIMH SBIR PA-14-172, Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44),


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2021	CONFOMRTRX INC	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	5	2/16/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	5	12/16/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $676,062 )
2021	2021	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	5	12/17/2020	NON-COMPETING CONTINUATION	$676,062
														Subtotal = $676,062

Issue Date FY: 2020 ( Subtotal = $676,062 )
2020	2020	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	4	12/20/2019	NON-COMPETING CONTINUATION	$676,062
														Subtotal = $676,062

Issue Date FY: 2019 ( Subtotal = $676,062 )
2019	2019	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	3	1/4/2019	EXTENSION WITH OR WITHOUT FUNDS	$676,062
														Subtotal = $676,062

Issue Date FY: 2018 ( Subtotal = $381,468 )
2018	2018	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	2	12/7/2017	NON-COMPETING CONTINUATION	$381,468
														Subtotal = $381,468

Issue Date FY: 2017 ( Subtotal = $376,468 )
2017	2017	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	001	1	12/31/2016	NEW	$0
2017	2017	CONFOMETRX	840 CHIMALUS DR	PALO ALTO	CA	94306	SANTA CLARA	USA	Mental Health Research Grants	000	1	12/27/2016	NEW	$376,468
														Subtotal = $376,468

Grand Total All Awards = $2,786,122

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Structure-based discovery of dopamine D1 receptor selective small molecule ligands

Award Number: R44MH112215

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/01/2017

PERIOD OF PERFORMANCE END DATE: 06/30/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer